• Profile
Close

Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes

Journal of Cystic Fibrosis Jun 14, 2018

Frost F, et al. - Researchers determined the impact of continuous glucose monitoring (CGM) guided insulin initiation on the outcomes (including weight and pulmonary function changes over the next 12 months) in adults without a prior diagnosis of cystic fibrosis related diabetes (CFRD) presented at their centre. They analyzed CGM profiles for 59 patients and started insulin therapy in 37 patients who had evidence of hyperglycaemia on CGM. Findings demonstrated that improvements in lung function (improved forced expiratory volume in 1 s) and weight with subsequent reduced pulmonary function decline was observed in association with insulin treatment targeted towards glycaemic excursions seen on CGM.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay